Found: 25
Select item for more details and to access through your institution.
Letter from Taiwan.
- Published in:
- Respirology, 2023, v. 28, n. 11, p. 1082, doi. 10.1111/resp.14572
- By:
- Publication type:
- Article
PM<sub>2.5</sub> exposure and risk of lung adenocarcinoma in women of Taiwan: A case–control study with density sampling.
- Published in:
- Respirology, 2022, v. 27, n. 11, p. 951, doi. 10.1111/resp.14316
- By:
- Publication type:
- Article
Positive blood culture is not associated with increased mortality in patients with sepsis-induced acute respiratory distress syndrome.
- Published in:
- Respirology, 2013, v. 18, n. 8, p. 1210, doi. 10.1111/resp.12121
- By:
- Publication type:
- Article
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192161
- By:
- Publication type:
- Article
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.671127
- By:
- Publication type:
- Article
Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 5, p. 775, doi. 10.1007/s10198-023-01624-4
- By:
- Publication type:
- Article
Health-related quality of life after first-line anti-cancer treatments for advanced non-small cell lung cancer in clinical practice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 13, p. 5939, doi. 10.1002/cam4.2485
- By:
- Publication type:
- Article
Improved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 182, doi. 10.1111/1759-7714.14237
- By:
- Publication type:
- Article
Rasch models suggested the satisfactory psychometric properties of the World Health Organization Quality of Life—Brief among lung cancer patients.
- Published in:
- Journal of Health Psychology, 2017, v. 22, n. 4, p. 397, doi. 10.1177/1359105315603474
- By:
- Publication type:
- Article
Comparison of Global Initiative for Chronic Obstructive Pulmonary Disease 2013 Classification and Body Mass Index, Airflow Obstruction, Dyspnea, and Exacerbations Index in Predicting Mortality and Exacerbations in Elderly Adults with Chronic Obstructive Pulmonary Disease
- Published in:
- Journal of the American Geriatrics Society, 2015, v. 63, n. 2, p. 244, doi. 10.1111/jgs.13258
- By:
- Publication type:
- Article
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918797589
- By:
- Publication type:
- Article
Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758834018755072
- By:
- Publication type:
- Article
Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8838, doi. 10.1002/cam4.5632
- By:
- Publication type:
- Article
Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91852-6
- By:
- Publication type:
- Article
Typical antipsychotics is associated with increased risk of severe exacerbation in asthma patients: a nationwide population-based cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Estimating the lifelong health impact and financial burdens of different types of lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30565-4
- By:
- Publication type:
- Article
Economic Analysis of Tissue-First, Plasma-First, and Complementary NGS Approaches for Treatment-Naïve Metastatic Lung Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.873111
- By:
- Publication type:
- Article
Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.760686
- By:
- Publication type:
- Article
Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231413
- By:
- Publication type:
- Article
Trend of Non-contrast Chest Computed Tomography Use in the Lung Cancer Screening Era: SEER-Medicare 2008–2016.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Downstream Complications and Healthcare Expenditure after Invasive Procedures for Lung Lesions in Taiwan.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 8, p. 4040, doi. 10.3390/ijerph18084040
- By:
- Publication type:
- Article
The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07423-w
- By:
- Publication type:
- Article
Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program.
- Published in:
- Addiction Science & Clinical Practice, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13722-022-00310-9
- By:
- Publication type:
- Article